Valuation: Ipsen

Market Cap 13.61B 15.58B 12.5B 11.66B 22.1B 1,483B 22.47B 151B 58.33B 727B 58.49B 57.22B 2,506B P/E 2026 *
15.1x
P/E 2027 * 14.8x
Enterprise Value 12.19B 13.95B 11.19B 10.44B 19.78B 1,328B 20.12B 135B 52.22B 651B 52.37B 51.23B 2,244B EV / Sales 2026 *
2.86x
EV / Sales 2027 * 2.49x
Free-Float
40.65%
Yield 2026 *
0.87%
Yield 2027 * 0.9%
1 day+3.20%
1 week+4.65%
Current month+1.36%
1 month+12.71%
3 months+3.63%
6 months+43.78%
Current year+43.78%
1 week 160
Extreme 160
171.1
1 month 148.7
Extreme 148.7
171.1
Current year 116
Extreme 116
173.5
1 year 101.2
Extreme 101.2
173.5
3 years 87.95
Extreme 87.95
173.5
5 years 77
Extreme 77
173.5
10 years 34.2
Extreme 34.2
173.5
Manager TitleAgeSince
Chief Executive Officer 59 2020-06-30
Chief Executive Officer 57 2019-12-31
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 61 2005-08-29
Chairman 68 2010-11-21
Director/Board Member 69 2012-05-31
Date Insider Type Main position Quantity % Market Cap.
05-31Fiscal year

Chief Executive Officer

-26,583 0.0317%
05-26Sell

Chief Executive Officer

-1,000 0.0012%
02-24Sell

Chairman

3,800 0.0045%
Change 5-day change 1-year change 3-year change Capi.($)
+3.20%+4.65%+65.47%+55.26% 15.5B
+1.86%+7.65%+55.77%+163.08% 1,063B
+3.57%+7.42%+69.09%+61.03% 611B
+3.99%+7.37%+36.87%+93.37% 444B
+4.17%-0.96%+26.12%+20.22% 324B
+4.94%+4.51%+39.76%+28.93% 285B
+2.42%+2.96%+30.77%+42.24% 283B
+2.47%+6.56%-24.26%-39.60% 219B
+3.55%+6.05%+26.04%+66.28% 195B
+4.21%+6.00%+17.72%+71.11% 156B
Average +3.35%+2.68%+34.34%+56.19% 359.62B
Weighted average by Cap. +2.97%+4.14%+41.70%+82.05%

Financials

2026 *2027 *
Net sales 4.27B 4.88B 3.92B 3.65B 6.92B 465B 7.04B 47.16B 18.28B 228B 18.33B 17.93B 785B 4.48B 5.13B 4.11B 3.84B 7.27B 488B 7.39B 49.53B 19.19B 239B 19.25B 18.83B 825B
Net income 940M 1.08B 863M 805M 1.53B 102B 1.55B 10.39B 4.03B 50.22B 4.04B 3.95B 173B 949M 1.09B 871M 812M 1.54B 103B 1.57B 10.49B 4.06B 50.69B 4.08B 3.99B 175B
Net Debt -1.43B -1.63B -1.31B -1.22B -2.31B -155B -2.35B -15.77B -6.11B -76.2B -6.13B -5.99B -263B -2.45B -2.81B -2.25B -2.1B -3.98B -267B -4.05B -27.12B -10.51B -131B -10.54B -10.31B -452B
Logo Ipsen
Ipsen specialises in the research, development, manufacture and marketing of specialty medicines. Net sales by therapeutic area break down as follows: - oncology (69.2%); - neuroscience (20.3%); - rare diseases (10.5%). At the end of 2025, the group had 7 research and development centers located in France (2), the United Kingdom (2), China (2) and Ireland, and 5 manufacturing sites worldwide. Net sales are distributed geographically as follows: France (8%), Europe (31.7%), the United States (32.9%), North America (2.2%) and other (25.2%).
Employees
5,535
Date Price Change Volume
26-07-02 171.10 +3.20% 134,415
26-07-01 €165.80 -1.78% 122,377
26-06-30 €168.80 +2.30% 128,092
26-06-29 €165.00 +1.60% 105,178
26-06-26 €162.40 +0.12% 100,683
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
171.10EUR
Average target price
161.33EUR
Spread / Average Target
-5.71%

Quarterly revenue - Rate of surprise